Loading...

Many Bright Ideas Technologies Inc.

MBGNFPNK
Healthcare
Medical - Diagnostics & Research
$0.01
$0.00(0.00%)

Many Bright Ideas Technologies Inc. (MBGNF) Financial Performance & Income Statement Overview

Analyze Many Bright Ideas Technologies Inc. (MBGNF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
0.00%
Operating Income Growth
11.35%
11.35%
Net Income Growth
11.35%
11.35%
Operating Cash Flow Growth
0.00%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
35.36%
35.36%
ROIC
32.27%
32.27%

Many Bright Ideas Technologies Inc. (MBGNF) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Many Bright Ideas Technologies Inc. MBGNF financial performance.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$0.00$0.00$0.00$0.00
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Gross Profit Ratio$0.00$0.00$0.00$0.00
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$12808.00$10804.00$19998.00$10086.00
Operating Expenses$12808.00$10804.00$19998.00$10132.00
Total Costs & Expenses-$12808.00$10804.00$19998.00$10132.00
Interest Income$0.00$0.00$0.00$0.00
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$0.00$0.00$0.00$8384.00
EBITDA-$12808.00-$10804.00-$19998.00-$1748.00
EBITDA Ratio
Operating Income-$12808.00$0.00-$19998.00-$10132.00
Operating Income Ratio
Other Income/Expenses (Net)$0.00$0.00$0.00$0.00
Income Before Tax-$12808.00-$10804.00-$19998.00-$10132.00
Income Before Tax Ratio
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$12808.00-$10804.00-$19998.00-$10132.00
Net Income Ratio
EPS-$0.001-$0.001-$0.001-$0.001
Diluted EPS-$0.001-$0.001-$0.001-$0.001
Weighted Avg Shares Outstanding$17.26M$17.26M$17.26M$17.26M
Weighted Avg Shares Outstanding (Diluted)$17.26M$17.26M$17.26M$17.26M

Over the past four quarters, Many Bright Ideas Technologies Inc. demonstrated steady revenue growth, increasing from $0.00 in Q1 2024 to $0.00 in Q4 2024. Operating income reached -$12808.00 in Q4 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$12808.00, reflecting operational efficiency. Net income dropped to -$12808.00, with EPS at -$0.001. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;